Literature DB >> 12866713

Mechanisms contributing to antidepressant zinc actions.

Gabriel Nowak1, Bernadeta Szewczyk.   

Abstract

Zinc is a trace element, which is an important modulator of mammalian nervous and immune systems. Its deficiency is related to human depression. Our recent data indicate involvement of zinc in the mechanism of antidepressant treatment. Moreover, zinc exhibits antidepressant-like effects in animal models of depression in rodents. Since zinc also enhances antidepressant effect in laboratory animals, its potential therapeutic value in human depression is under evaluation. This article reviews the alterations in central and peripheral zinc homeostasis in relation to pathophysiology and treatment of depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12866713

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  5 in total

1.  Zinc and fatty acids in depression.

Authors:  Gisela Irmisch; Detlef Schlaefke; Joerg Richter
Journal:  Neurochem Res       Date:  2010-06-04       Impact factor: 3.996

2.  Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.

Authors:  Andreas M Grabrucker; Magali Rowan; Craig C Garner
Journal:  Drug Deliv Lett       Date:  2011-09

3.  Modulation of antidepressant-like activity of magnesium by serotonergic system.

Authors:  E Poleszak
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

4.  Lower Serum Zinc and Higher CRP Strongly Predict Prenatal Depression and Physio-somatic Symptoms, Which All Together Predict Postnatal Depressive Symptoms.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; Boris Mahieu; Gabriel Nowak; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-02-05       Impact factor: 5.590

5.  Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences.

Authors:  Andreas M Grabrucker; Craig C Garner; Tobias M Boeckers; Lucia Bondioli; Barbara Ruozi; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.